CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-15 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +23,900 | 23,900 | ||
| 2017-06-15 | Adams Robert W Director | Grant or award · Stock Option (Right to Buy) | +23,900 | 23,900 | ||
| 2017-06-15 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +23,900 | 23,900 | ||
| 2017-05-10 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +41,000 | 41,000 | ||
| 2017-05-10 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +34,000 | 34,000 | ||
| 2017-05-10 | Shealy Ben Sr VP Finance & Treasurer | Grant or award · Stock Option (Right to Buy) | +23,100 | 23,100 | ||
| 2017-05-10 | Shealy Ben Sr VP Finance & Treasurer | Grant or award · Stock Option (Right to Buy) | +23,100 | 23,100 | ||
| 2017-05-10 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +34,000 | 34,000 | ||
| 2017-05-10 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +41,000 | 41,000 | ||
| 2017-01-03 | Byrne Thomas E General Counsel | Grant or award · Stock Option (Right to Buy) | +4,673 | 4,673 | ||
| 2016-12-28 | Giles Mark T Director | Purchase | +290,580 | 802,689 | ||
| 2016-12-27 | Giles Mark T Director | Other disposition | −290,580 | 0 | ||
| 2016-12-15 | Giles Mark T Director | Purchase | +512,109 | 512,109 | ||
| 2016-12-14 | Giles Mark T Director | Other disposition | −339,055 | 290,580 | ||
| 2016-12-08 | Adams Robert W Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2016-12-08 | Gainer John Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +34,000 | 34,000 | ||
| 2016-12-08 | Shealy Ben Sr VP Finance & Treasurer | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2016-12-08 | Giles Mark T Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2016-12-08 | Kalergis David G Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2016-12-08 | LEVIN ALAN G Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 |
Page 11 of 17 · 321 trades